ArticleCureus2025
Carbamazepine-Induced Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a severe and potentially life-threatening adverse reaction to medications. The exact underlying mechanisms of DRESS syndrome remain incompletely understood. The most frequent manifestations include fever, cutaneous rash, lymphadenopathy, and deranged hepatic biochemistry. Timely identification and cessation of the offending drug is critical in the effective management of the syndrome. Most patients with DRESS syndrome experience complete recovery upon discontinuation of the causative drug. A subset of patients may experience a protracted course with relapses and autoimmune complications, such as autoimmune thyroiditis or type 1 diabetes, necessitating long-term monitoring. Here, we report a case of carbamazepine-induced DRESS syndrome. In this case, prompt cessation of carbamazepine and treatment with systemic steroids led to complete resolution of symptoms and normalization of liver function. This case underscores the importance of promptly recognizing and managing this condition to ensure favorable outcomes and patient safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.